XML 42 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
VCTF warrant
Equity Financing Program
ECARX Holdings, Inc. (ECX)
Freedom Photonics
Solfice
TPK Universal Solutions Limited
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
VCTF warrant
Additional Paid-in Capital
Equity Financing Program
Additional Paid-in Capital
ECARX Holdings, Inc. (ECX)
Additional Paid-in Capital
Freedom Photonics
Additional Paid-in Capital
Solfice
Additional Paid-in Capital
TPK Universal Solutions Limited
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Accumulated Deficit
Class A Common Stock
Class A Common Stock
Common Stock
Class A Common Stock
Common Stock
Equity Financing Program
Class A Common Stock
Common Stock
ECARX Holdings, Inc. (ECX)
Class A Common Stock
Common Stock
Freedom Photonics
Class A Common Stock
Common Stock
Solfice
Class A Common Stock
Common Stock
TPK Universal Solutions Limited
Class B Common Stock
Class B Common Stock
Common Stock
Beginning balance (in shares) at Dec. 31, 2021                                       17,721,742             6,472,578
Beginning balance at Dec. 31, 2021 $ 197,985               $ 1,257,248             $ (908) $ (235,871) $ (822,487)   $ 2             $ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                      
Shares repurchased (76,606)                               (76,606)                    
Issuance of Class A common stock upon exercise of Private Warrants (in shares)                                       27,049              
Issuance of Class A common stock upon exercise of Private Warrants 19,003               19,003                                    
Issuance of Class A common stock (in Shares)                                       610,385              
Issuance of Class A common stock 3,945               3,945                                    
Issuance of Class A common stock under ESPP (in shares)                                       11,129              
Issuance of Class A common stock under ESPP 1,271               1,271                                    
Retirement of unvested restricted common stock (in shares)                                     (439,979) (3,212)              
Retirement of unvested restricted common stock 0                                                    
Vendor payments under the stock-in-lieu of cash program (in shares)                                       663,284              
Vendor payments under the stock in lieu of cash program 80,255               80,255                                    
Investment in ECARX Holdings, Inc. (in shares)                                           135,358          
Investment in ECARX Holdings, Inc.       $ 12,588               $ 12,588                              
Optogration milestone awards (in shares)                                       108,799              
Optogration milestone awards 11,751               11,751                                    
Acquisition of Freedom Photonics LLC /certain assets from Solfice Research, Inc. (in shares)                                             145,065 24,946      
Acquisition of Freedom Photonics LLC /certain assets from Solfice Research, Inc.         $ 30,510 $ 3,361             $ 30,510 $ 3,361                          
Stock-based compensation 142,519               142,519                                    
Other comprehensive (loss) income (3,318)                             (3,318)                      
Payments of employee taxes related to stock-based awards (3,730)               (3,730)                                    
Net loss (445,939)                                 (445,939)                  
Ending balance (in shares) at Dec. 31, 2022                                       19,444,545             6,472,578
Ending balance at Dec. 31, 2022 (26,405)               1,558,721             (4,226) (312,477) (1,268,426)   $ 2             $ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                      
Issuance of Class A common stock (in Shares)                                       1,239,246 631,191       220,384    
Issuance of Class A common stock 3,056   $ 50,190       $ 20,000   3,056   $ 50,190       $ 20,000                        
Issuance of Class A common stock under ESPP (in shares)                                       47,147              
Issuance of Class A common stock under ESPP 2,641               2,641                                    
Issuance of Class A common stock to Plus AI (in shares)               128,431                                      
Issuance of Class A common stock to Plus AI 12,141               12,141                                    
Vendor payments under the stock-in-lieu of cash program (in shares)                                       1,045,115              
Vendor payments under the stock in lieu of cash program 75,873               75,873                                    
Milestone awards relating to acquisitions (in shares)                                       196,221              
Milestone awards relating to acquisitions 20,656               20,656                                    
Stock-based compensation 186,278               186,278                                    
Other comprehensive (loss) income 4,228                             4,228                      
Payments of employee taxes related to stock-based awards (2,137)               (2,137)                                    
Net loss (571,269)                                 (571,269)                  
Ending balance (in shares) at Dec. 31, 2023                                     21,494,717 22,952,280           6,472,578 6,472,578
Ending balance at Dec. 31, 2023 (224,748)               1,927,419             2 (312,477) (1,839,695)   $ 2             $ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                      
Issuance of Class A common stock (in Shares)                                       2,456,525 8,335,450            
Issuance of Class A common stock 548   $ 89,359           548   $ 89,358                   $ 1            
Issuance of Class A common stock under ESPP (in shares)                                       63,675              
Issuance of Class A common stock under ESPP 1,153               1,153                                    
Issuance of Class A common stock to Plus AI (in shares)                                       46,978              
Issuance of Class A common stock to Plus AI 1,842               1,842                                    
Issuance of Class A common stock under 401(k) Plan (in shares)                                       99,652              
Issuance of Class A common stock under 401(k) Plan 2,550               2,550                                    
Issuance of Class A common stock upon conversion of 2030 Convertible Notes (in shares)                                       1,980,408              
Issuance of Class A common stock upon conversion of 2030 Convertible Notes 28,945               28,945                                    
Vendor payments under the stock-in-lieu of cash program (in shares)                                       129,959              
Vendor payments under the stock in lieu of cash program 5,473               5,473                                    
Milestone awards relating to acquisitions (in shares)                                       391,749              
Milestone awards relating to acquisitions 11,250               11,250                                    
Conversion of Class B common stock to Class A common stock (in shares)                                       1,600,000             (1,600,000)
Expense related to Volvo Warrants   $ 642               $ 642                                  
Stock-based compensation 137,631               137,631                                    
Other comprehensive (loss) income (297)                             (297)                      
Payments of employee taxes related to stock-based awards (1,997)               (1,997)                                    
Net loss (273,140)                                 (273,140)                  
Ending balance (in shares) at Dec. 31, 2024                                     36,599,113 38,056,676           4,872,578 4,872,578
Ending balance at Dec. 31, 2024 $ (220,789)               $ 2,204,814             $ (295) $ (312,477) $ (2,112,835)   $ 3             $ 1